With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class rare disease drug DIAG723. The Massachusetts-based biotech, which develops ...
WATERTOWN, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe ...
There may have been a bit of controversy at the end of the Diagonal Labor Day Parade — a float that pokes fun at President Joe Biden.People on the float were wearing turbans and signs on the float ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results